Eurosurveillance
Volume 19, Issue 45, 13 November 2014
http://www.eurosurveillance.org/Public/Articles/Archives.aspx?PublicationId=11678

The Innovative Medicines Initiative launches call on Ebola and other filoviral haemorrhagic fevers
Eurosurveillance editorial
On 6 November 2014, the Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU) [1] launched its second Call for Proposals in the framework of the IMI2 ‘Ebola and other filoviral haemorrhagic fevers programme (the Ebola+ programme)’ [2]. Submissions for the Call can be made as of 22 November and closes on 1 December, and has an indicative budget of € 140 million.
The following topics are covered in the Call for proposals:
Topic 1: Vaccine development Phase I, II, and III
Topic 2: Manufacturing capability
Topic 3: Stability of vaccines during transport and storage
Topic 4: Deployment and compliance of vaccination regimens
Topic 5: Rapid diagnostic tests
The Call and its topics will be further explained in a 17 November webinar.